NEW YORK, Feb. 18 (GenomeWeb News) - Shares in Bio-Rad were down 10.48 percent, or $6.07, at $51.83 in late-afternon trading after lackluster fourth-quarter earnings caused an investment bank to downgrade the stock today.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.